# Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision Lumpectomy

> **NCT01568346** · PHASE3 · TERMINATED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 9 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** MRI

## Key facts

- **NCT ID:** NCT01568346
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-02
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Slow Accural
- **Last updated:** 2016-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01568346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01568346, "Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision Lumpectomy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01568346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*